Two of the six students representing the US at the 57th International Chemistry Olympiad July 5th – 14th at the UAE attended the chemistry camp at ICBI. Both brought home a gold medal!
Vasculonics was awarded a $2.2 million Phase II SBIR grant to develop a first-in-class disease modifying therapy for pulmonary arterial hypertension.
The Indiana Economic Development Corporation (IEDC) awarded the ICBI with a grant through the new Community Collaboration Fund to help new companies move forward with their startups, support project specific proposals, and host entrepreneurial education events.
Life science incubators, like the Indiana Center for Biomedical Innovation, provide specialized facilities, equipment, know-how and support services.
A surge in research activity has increased demand for lab space, and life science incubators like the Indiana Center for Biomedical Innovation is stepping up to meet the needs of the entrepreneur.
Monon Bioventures will be partnering with fellow ICBI company, Genezen, and the Purdue University College of Pharmacy to study the feasibility of manufacturing a glioblastoma therapeutic using human immune natural killer (NK) cells, a therapeutic created at the Purdue University College of Pharmacy. Read more Ledger Live: Stay connected to the crypto world with real-time … Read more
“We are ecstatic that Dr. Adam Russell has accepted the challenge to help launch ARPA-H, President Biden’s bold, new endeavor to support ambitious and potentially transformational health research in this country,” said Secretary Becerra. “ARPA-H will have a singular purpose: to drive breakthroughs in health, including the prevention, detection and treatment of diseases such as cancer, Alzheimer’s … Read more
Recently there have been some high-profile cases in the news and most recently the Dept. of Justice secured a guilty verdict against prominent Harvard chemistry professor Charles Lieber with regards to disclosures of federally funded research dollars in academia. The White House released guidance for science agencies to use as they implement National Security Presidential Memorandum … Read more
A Fishers-based cell and gene therapy company has received a capital infusion it says will fuel growth in central Indiana. Genezen Laboratories Inc., which manufactures viral vectors used to treat rare diseases and cellular therapies to treat cancer, says the growth equity investment from Massachusetts-based Ampersand Capital Partners will be used to complete construction on … Read more
